Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Corcept Therapeutics
Corcept Therapeutics
NGM Biopharmaceuticals, Inc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Corcept Therapeutics
GOG Foundation
Ohio State University Comprehensive Cancer Center
GOG Foundation
University of Iowa
University of Washington
OHSU Knight Cancer Institute
Accelerated Community Oncology Research Network